Development and implementation of optimized endogenous contrast sequences for delineation in adaptive radiotherapy on a 1.5T MR-Linear-accelerator (MR-Linac): A prospective R-IDEAL Stage 0-2a quantitative/qualitative evaluation of in vivo site-specific quality-assurance using a 3D T2 fat-suppressed platform for head and neck cancer

Travis C. Salzillo, M. Alex Dresner, Ashley Way, Kareem A. Wahid, Brigid A. McDonald, Sam Mulder, Mohamed A. Naser, Renjie He, Yao Ding, Alison Yoder, Sara Ahmed, Kelsey L. Corrigan, Gohar S. Manzar, Lauren Andring, Chelsea Pinnix, R. Jason Stafford, Abdallah S.R. Mohamed, John Christodouleas, Jihong Wang, Clifton David Fuller
doi: https://doi.org/10.1101/2022.06.24.22276839

Data Availability

All data produced are available online on FigShare (DOI: 10.6084/m9.figshare.20140184)

https://figshare.com/articles/dataset/Fat-suppressed_SPAIR_T2-weighted_MRI_sequences_for_head_and_neck_imaging_on_the_MR-Linac/20140184

Back to top
Posted June 27, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Development and implementation of optimized endogenous contrast sequences for delineation in adaptive radiotherapy on a 1.5T MR-Linear-accelerator (MR-Linac): A prospective R-IDEAL Stage 0-2a quantitative/qualitative evaluation of in vivo site-specific quality-assurance using a 3D T2 fat-suppressed platform for head and neck cancer
Travis C. Salzillo, M. Alex Dresner, Ashley Way, Kareem A. Wahid, Brigid A. McDonald, Sam Mulder, Mohamed A. Naser, Renjie He, Yao Ding, Alison Yoder, Sara Ahmed, Kelsey L. Corrigan, Gohar S. Manzar, Lauren Andring, Chelsea Pinnix, R. Jason Stafford, Abdallah S.R. Mohamed, John Christodouleas, Jihong Wang, Clifton David Fuller
medRxiv 2022.06.24.22276839; doi: https://doi.org/10.1101/2022.06.24.22276839
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area